News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
606,160 Results
Type
Article (40376)
Company Profile (207)
Press Release (565577)
Section
Business (182414)
Career Advice (2011)
Deals (30634)
Drug Delivery (109)
Drug Development (63294)
Employer Resources (170)
FDA (14057)
Job Trends (13192)
News (295928)
Policy (25729)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (9)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (1)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2418)
Academic (2)
Accelerated approval (2)
Adcomms (20)
Allergies (68)
Alliances (48850)
ALS (71)
Alzheimer's disease (1189)
Antibody-drug conjugate (ADC) (109)
Approvals (14062)
Artificial intelligence (262)
Autoimmune disease (10)
Automation (14)
Bankruptcy (261)
Best Places to Work (10602)
BIOSECURE Act (18)
Biosimilars (82)
Biotechnology (140)
Bladder cancer (52)
Brain cancer (18)
Breast cancer (220)
Cancer (1754)
Cardiovascular disease (139)
Career advice (1717)
Career pathing (33)
CAR-T (140)
Cell therapy (388)
Cervical cancer (19)
Clinical research (50505)
Collaboration (764)
Compensation (210)
Complete response letters (13)
COVID-19 (2201)
CRISPR (40)
C-suite (190)
Cystic fibrosis (90)
Data (1704)
Decentralized trials (2)
Denatured (35)
Depression (33)
Diabetes (215)
Diagnostics (6149)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (113)
Drug pricing (85)
Drug shortages (23)
Duchenne muscular dystrophy (73)
Earnings (71761)
Editorial (32)
Employer branding (25)
Employer resources (144)
Events (92060)
Executive appointments (580)
FDA (15012)
Featured Employer (46)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (661)
Gene editing (94)
Generative AI (27)
Gene therapy (262)
GLP-1 (619)
Government (3274)
Grass and pollen (2)
Guidances (40)
Healthcare (16384)
Huntington's disease (18)
IgA nephropathy (17)
Immunology and inflammation (81)
Indications (23)
Infectious disease (2318)
Inflammatory bowel disease (123)
Inflation Reduction Act (10)
Influenza (44)
Intellectual property (79)
Interviews (337)
IPO (14315)
IRA (34)
Job creations (3026)
Job search strategy (1462)
Kidney cancer (5)
Labor market (33)
Layoffs (333)
Leadership (16)
Legal (6261)
Liver cancer (57)
Lung cancer (260)
Lymphoma (108)
Machine learning (2)
Management (53)
Manufacturing (248)
MASH (51)
Medical device (12992)
Medtech (12997)
Mergers & acquisitions (16811)
Metabolic disorders (553)
Multiple sclerosis (58)
NASH (16)
Neurodegenerative disease (62)
Neuropsychiatric disorders (15)
Neuroscience (1588)
NextGen: Class of 2025 (5877)
Non-profit (3740)
Northern California (2011)
Now hiring (36)
Obesity (291)
Opinion (194)
Ovarian cancer (71)
Pain (71)
Pancreatic cancer (66)
Parkinson's disease (112)
Partnered (20)
Patents (190)
Patient recruitment (81)
Peanut (40)
People (51638)
Pharmaceutical (42)
Pharmacy benefit managers (9)
Phase I (16003)
Phase II (21947)
Phase III (16913)
Pipeline (897)
Podcasts (96)
Policy (98)
Postmarket research (2061)
Preclinical (7230)
Press Release (71)
Prostate cancer (89)
Psychedelics (28)
Radiopharmaceuticals (219)
Rare diseases (298)
Real estate (5243)
Recruiting (66)
Regulatory (17760)
Reports (51)
Research institute (2218)
Resumes & cover letters (301)
Rett syndrome (2)
RNA editing (3)
RSV (34)
Schizophrenia (55)
Series A (122)
Series B (73)
Service/supplier (12)
Sickle cell disease (44)
Southern California (1747)
Special edition (11)
Spinal muscular atrophy (121)
Sponsored (25)
Startups (3438)
State (2)
Stomach cancer (11)
Supply chain (46)
The Weekly (59)
United States (18330)
Vaccines (573)
Venture capitalists (34)
Webinars (13)
Weight loss (196)
Women's health (29)
Worklife (16)
Date
Today (104)
Last 7 days (513)
Last 30 days (2256)
Last 365 days (29898)
2025 (7027)
2024 (31474)
2023 (35734)
2022 (45760)
2021 (49678)
2020 (47810)
2019 (41652)
2018 (31345)
2017 (29541)
2016 (28879)
2015 (33728)
2014 (26926)
2013 (23173)
2012 (24378)
2011 (24433)
2010 (23242)
Location
Africa (769)
Alabama (48)
Alaska (7)
Arizona (176)
Arkansas (12)
Asia (36144)
Australia (6220)
California (4644)
Canada (1618)
China (419)
Colorado (229)
Connecticut (240)
Delaware (117)
Europe (80253)
Florida (735)
Georgia (178)
Hawaii (1)
Idaho (46)
Illinois (433)
India (25)
Indiana (273)
Iowa (7)
Japan (133)
Kansas (93)
Kentucky (13)
Louisiana (9)
Maine (60)
Maryland (696)
Massachusetts (3490)
Michigan (208)
Minnesota (339)
Mississippi (2)
Missouri (70)
Montana (26)
Nebraska (20)
Nevada (52)
New Hampshire (69)
New Jersey (1449)
New Mexico (24)
New York (1394)
North Carolina (839)
North Dakota (8)
Northern California (2011)
Ohio (165)
Oklahoma (14)
Oregon (32)
Pennsylvania (1035)
Puerto Rico (8)
Rhode Island (25)
South America (1072)
South Carolina (19)
South Dakota (1)
Southern California (1747)
Tennessee (84)
Texas (721)
Utah (153)
Virginia (109)
Washington D.C. (53)
Washington State (447)
West Virginia (3)
Wisconsin (53)
606,160 Results for "wexford science and technology llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
February 24, 2025
·
6 min read
Press Releases
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq’s Novel Surface Treatment Technology
February 19, 2025
·
3 min read
Press Releases
Cycle Pharma Acquires Banner Life Sciences, LLC
January 13, 2025
·
17 min read
Business
Andelyn Biosciences and Grace Science, LLC Partner to Tech Transfer Phase I/II/III Manufacturing of a Suspension Process Adeno-Associated Virus (AAV) Gene Therapy for NGLY1 Deficiency
Andelyn Biosciences has partnered with Grace Science, LLC, to tech transfer and manufacture GS-100, a suspension process AAV NGLY1 gene therapy for Phase I/II/III clinical trial material for the treatment of NGLY1 Deficiency.
March 25, 2024
·
3 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
Press Releases
PANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE™ (vigabatrin) Oral Solution
March 25, 2025
·
3 min read
Press Releases
Afton Scientific, LLC Announces the Appointment of Jason Spacek and Jesse Boyd as Chief Commercial Officer and Chief Financial Officer
March 27, 2025
·
1 min read
Press Releases
Kashiv BioSciences, LLC Obtains Marketing Authorization for Pegfilgrastim Injection from Health Canada
February 26, 2025
·
2 min read
Press Releases
ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts
March 5, 2025
·
6 min read
FDA
Grace Science, LLC Selected by FDA to Participate in the START Pilot Program for GS-100 Gene Therapy for NGLY1 Deficiency and Announcement of the Successful Treatment of the 2nd Patient
Grace Science, LLC announced today that the IND for GS-100, an AAV9 gene therapy for NGLY1 Deficiency, was accepted into the FDA’s Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program.
June 3, 2024
·
3 min read
1 of 60,616
Next
